About: http://webisa.webdatacommons.org/323001881

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	The company is a leader in the field of immunotherapy, with ipilimumab already on the market for melanoma, and nivolumab now placed as the most advanced immunotherapeutic for NSCLC.
http://www.w3.org/ns/prov#wasQuotedFrom	lcfamerica.org